Healthstream (HSTM) EBITDA (2010 - 2026)

Healthstream (HSTM) has 17 years of EBITDA data on file, last reported at $7.5 million in Q1 2026.

• On a quarterly basis, EBITDA rose 71.59% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $23.4 million, a 16.99% increase from a year earlier, with the FY2025 full-year figure at $20.2 million, down 4.94% from the prior year.
• EBITDA for Q1 2026 stood at $7.5 million, up from $2.4 million in the prior quarter.
• Over the last five years, EBITDA for HSTM reached as high as $7.6 million in Q3 2025 and fell as low as $2.4 million in Q3 2022.
• Historically, EBITDA has averaged $4.6 million across 5 years, with a median of $4.4 million in 2025.
• Across the five-year window, EBITDA surged 768.91% in 2022 and slumped 48.73% in 2025, its largest moves.
• Year by year, EBITDA stood at $3.1 million in 2022, then jumped by 38.25% to $4.3 million in 2023, then gained by 10.23% to $4.7 million in 2024, then plunged by 48.73% to $2.4 million in 2025, then soared by 212.48% to $7.5 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $7.5 million in Q1 2026, $2.4 million in Q4 2025, and $7.6 million in Q3 2025.